Literature DB >> 9293043

Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users.

L Topp1, R P Mattick.   

Abstract

In order to ascertain a cut-off score on the Severity of Dependence Scale (SDS) which is indicative of clinically significant amphetamine dependence, 327 regular amphetamine users were administered the SDS, along with the "Disorders resulting from the use of psychoactive substances" section of the Composite International Diagnostic Interview (CIDI) for DSM-III-R. Receiver operating characteristic (ROC) analysis was used in order to determine which cut-off score on the SDS allowed the best trade-off between sensitivity and specificity, when calibrated against the presence or absence of a DSM-III-R diagnosis of severe amphetamine dependence. Results suggest that the SDS has high diagnostic utility, and that a score of greater than four on the scale is indicative of problematic amphetamine use.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293043

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  26 in total

1.  Severity of khat dependence among adult khat chewers: the moderating influence of gender and age.

Authors:  Motohiro Nakajima; Anisa Dokam; Abed Alsameai; Mohammed AlSoofi; Najat Khalil; Mustafa al'Absi
Journal:  J Ethnopharmacol       Date:  2014-07-23       Impact factor: 4.360

2.  Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study.

Authors:  Christina S Meade; Sheri L Towe; Melissa H Watt; Ryan R Lion; Bronwyn Myers; Donald Skinner; Stephen Kimani; Desiree Pieterse
Journal:  Drug Alcohol Depend       Date:  2015-04-30       Impact factor: 4.492

3.  Intimate partner violence among men and women who use methamphetamine: A mixed-methods study in South Africa.

Authors:  Melissa H Watt; Kathryn E Guidera; Andréa L Hobkirk; Donald Skinner; Christina S Meade
Journal:  Drug Alcohol Rev       Date:  2016-06-01

Review 4.  On beyond urine: clinically useful assessment instruments in the treatment of drug dependence.

Authors:  K M Carroll; B J Rounsaville
Journal:  Behav Res Ther       Date:  2002-11

5.  Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care Settings.

Authors:  Suzanne Nielsen; Louisa Picco; Gabrielle Campbell; Nicholas Lintzeris; Briony Larance; Michael Farrell; Louisa Degenhardt; Raimondo Bruno
Journal:  Pain Med       Date:  2020-02-01       Impact factor: 3.750

6.  Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China.

Authors:  Yingying Ding; Na He; Steven Shoptaw; Meiyang Gao; Roger Detels
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-29       Impact factor: 4.328

7.  Adapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trial.

Authors:  Phillip O Coffin; Glenn-Milo Santos; Grant Colfax; Moupali Das; Tim Matheson; Erin DeMicco; James Dilley; Eric Vittinghoff; Jerris L Raiford; Monique Carry; Jeffrey H Herbst
Journal:  AIDS Behav       Date:  2014-07

8.  Addiction potential of phentermine prescribed during long-term treatment of obesity.

Authors:  E J Hendricks; M Srisurapanont; S L Schmidt; M Haggard; S Souter; C L Mitchell; D G De Marco; M J Hendricks; Y Istratiy; F L Greenway
Journal:  Int J Obes (Lond)       Date:  2013-05-17       Impact factor: 5.095

9.  Treatment utilization and barriers to treatment: results of a survey of dependent methamphetamine users.

Authors:  Pauline Kenny; Angela Harney; Nicole K Lee; Amy Pennay
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-02-14

10.  Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care.

Authors:  Espen Saxhaug Kristoffersen; Jørund Straand; Jūratė Saltytė Benth; Michael Bjørn Russell; Christofer Lundqvist
Journal:  BMC Neurol       Date:  2012-08-10       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.